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Background: Silent information regulator 2 related enzyme 1 (SIRT1) is one of the key factors in the mechanism of
calorie restriction (CR) extending lifespan of animals. The aim of the study is to investigate if CR prolongs ovarian
lifespan in mice through activating SIRT1 signaling.
Methods: In the present study, 21 female C57BL/6 mice were divided into three groups: the control (n = 7), CR
(n = 7), and SRT1720 (n = 7) groups. After the 26-week treatment, the number of ovarian follicles at each stage was
counted, and Western blot was performed.
Results: The number of surviving follicles in ovaries of the SRT1720 group was less than that of the CR group but
more than that of the normal control (NC) group. The number of atretic follicles in the ovaries of the SRT1720
group was similar to that of the CR group but less than that of the NC group. The number of primordial follicles in
the ovaries of the SRT1720 group was less than that of the CR group but more than that of the NC group. The
numbers of primary follicles, secondary follicles, antral follicles, and corpora lutea in the SRT1720 group were similar
to those in the CR group. Western blot analysis showed that the expression of SIRT1, SIRT6, FOXO3a, and NRF1
proteins was upregulated, and p53 was downregulated in both the CR group and the SRT1720 group compared to
the control group.
Conclusions: Our results indicate that CR inhibits the activation of primordial follicles and development of follicles
at different stages, thus preserving the reserve of follicle pool (at least partly) through activating SIRT1 signaling.
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Mammalian females possess a finite number of primordial
follicles at birth, following the formation of the primordial
follicle pool. Cohorts of these follicles are recruited to
begin maturation but the ova do not proliferate, resulting
in recruitment continuing until the primordial follicle
population becomes depleted. These processes directly
affect the number of oocytes available to a female through-
out her reproductive life [1]. Once the pool of primordial
follicles is depleted, a series of physiological changes
known as menopause occur. Inappropriate coordination of* Correspondence: ycfu@stu.edu.cn; luolili6606@163.com
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unless otherwise stated.these processes contributes to ovarian pathologies, such as
premature ovarian failure (POF) and infertility. Therefore,
if we can intervene follicle development and follicle loss,
the female reproductive life can be extended, the post-
menopausal period can be shortened, and female life qual-
ity can be enhanced.
Previous studies showed that calorie restriction (CR) is
the only non-genetic intervention that has increased the
lifespan and delayed age-associated physiological deteri-
oration in species ranging from yeast to mammals [2-4].
Moreover, CR can prolong female reproductive life [5],
maintain the follicle reserve [6], and delay ovarian failure
of adult rats [7]. However, the molecular mechanism of
CR involved in ovarian follicle development and ovarian
lifespan is not clear.s is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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is a dependent histone deacetylase which is closely related
to a cell differentiation, senescence, apoptosis, and energy
metabolism. Accumulating evidence has demonstrated that
SIRT1 is required for CR to mediate lifespan extension in
mammals [8,9]. Our previous study showed that CR inhib-
ited the transition from primordial to developing follicles
and extended the entire growth phase of a follicle to pre-
serve the reserve of germ cells and suggested that SIRT1
and SIRT6 might be both associated with these CR effects
[10]. SIRT1 transgenic mice showed phenotypes resem-
bling CR and delayed sexual maturity, suggesting that
SIRT1 may suppress ovarian follicle development and mat-
uration [11]. Therefore, we suppose that SIRT1 may play a
key role in CR effects on ovarian follicle development.
SRT1720 is a specific SIRT1 activator that has showed
health and lifespan benefits in adult mice fed a high-fat diet
with a higher dose (100 mg/kg body weight) and a lower
dose of SRT1720 (30 mg/kg) [12]. It was also found that
SRT1720 could extend lifespan, delay onset of age-related
metabolic diseases, and improve general health in mice fed
a standard diet [13].
It has been noted that SIRT1 targets are presumably af-
fected by CR. Forkhead box group O (FOXO3a) is an im-
portant substrate of SIRT1, and FOXO3a−/− mice showed
over-activation of primordial follicles and POF [14]. Sexual
maturity is delayed and follicle development is inhibited in
FOXO3a transgenic mice [15]. Nuclear respiratory factor 1
(NRF1) is known to regulate mtDNA replication and tran-
scription in various tissues [16] and identified as a nuclear
transcription factor that trans-activates the promotors of a
number of mitochondrial genes [17]. These include re-
spiratory subunits and factors involved in the replication
and transcription of mtDNA. Our previous study demon-
strated that CR extended ovarian lifespan by increasing the
follicle reserve, and the expression levels of SIRT1, SIRT6,
FOXO3a, and NRF1 proteins in the ovaries were also in-
creased [18], suggesting the involvement of SIRT1, SIRT6,
FOXO3a, and NRF1 in CR effects on ovarian follicle devel-
opment. In addition, a recent study revealed that glucose
deprivation enhanced the formation of a SIRT1-FOXO3a-
NRF1 protein complex on the SIRT6 promoter that is re-
sponsible for the induction of SIRT6 expression [19]. p53
is regulated by SIRT1-mediated deacetylation. The expres-
sion of p53 protein in the apoptotic granulosa cells of
atretic follicles suggests its possible role in atresia [20]. This
role of p53 is supported by several experiments [21]: (i) in-
hibition of p53 expression is associated with a marked re-
duction in the number of apoptotic granulosa cells and
atretic follicles [22]; (ii) overexpression of p53 can induce
apoptosis in cAMP-stimulated cells. Moreover, negative
p53 patterns may be a favorable prognostic finding show-
ing genome integrity in the replicating follicle cells of
women of reproductive age [23].Based on these data, we suppose that CR may suppress
ovarian follicle development and follicle loss by activating
SIRT1-FOXO3a-NRF1-SIRT6 signaling and inhibiting
some of SIRT1 target molecules such as p53, thus extend-
ing the ovarian lifespan of female mice. The present study
examined effects of SRT1720 and CR on the follicle devel-
opment and follicle loss, as well as the expression of key
molecules in SIRT1 signaling such as SIRT1, SIRT6,




Twenty-one 8-week-old female C57BL/6 mice (body
weight :19 ± 1.1 g) were purchased from the Medical Ex-
perimental Animal Center of Guangdong Province and
housed three or four in stainless steel cages in a room
with an ambient temperature of 22°C ± 2°C and a 12-h
light: 12-h dark cycle. All animal protocols were ap-
proved by the Institutional Animal Care and Use Com-
mittee of Shantou University. All the mice were
provided a standard rodent chow (20.11% protein, 4.84%
lipid, 7.34% crude fiber; total energy 17.3282 MJ/kg) and
tap water ad libitum for 6 weeks before their division
into three groups: the normal control (NC) group, the
CR group, and the SRT1720 group. The mice of the NC
group were fed ad libitum the standard rodent chow.
The CR group was subjected to a 30% reduction in the
total amount of food that was consumed by the NC
group. The SRT1720 group was firstly fed ad libitum the
standard chow for the first 18 weeks and then given the
standard chow containing SRT1720 (50 mg/kg B.W.)
every other day for the last 8 weeks.
The food intake of the mice was measured once every
month. According to the NC group, the food intake of
the CR group was timely modulated. Body weight was
measured once a month. Estrous cycle was examined by
vaginal smears once a month over more than 16 days.
After 26 weeks, mice were anesthetized with pentobar-
bital sodium at 40 mg/kg body weight, and sacrificed by
cervical dislocation. Mouse perirenal fat was isolated
and weighed and expressed as visceral fat index. Both
ovaries of each mouse were removed and weighed. One
was stored at −80°C for Western blot analysis. The other
one was used for histological analysis.
Estrous cycle analysis
Vaginal cytology was assessed daily between 9:00 AM and
10:00 AM before and until the end of the treatment to de-
termine the estrous cycle of each mouse. Vaginal cells were
collected via a sterile cotton swab saturated with normal sa-
line (NaCl, 0.9%), and then placed on a clean glass slide to
form well-proportioned tracks of smears. The smears were
























Figure 1 Mouse energy intake (the mice in the SRT1720 group
were given the standard chow containing SRT1720 (50 mg/kg
B.W.) every other day for the last 8 weeks). CR, calorie restriction;
NC, normal control.
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estrus smear consisted of predominantly nucleated corni-
fied cells; an estrus smear consisted primarily of anucleated
cornified cells; a metestrus smear consisted of an equal pro-
portion of leukocytes, cornified, and nucleated epithelial
cells; and a diestrus smear consisted of primarily leuko-
cytes. A 4- to 5-day estrous cycle was determined to be a
regular cycle, and a cycle duration of >5 days or <4 days
was considered to be an irregular cycle [25].
Preparation of ovarian sections
One of the two ovaries from each mouse was fixed in
4% paraformaldehyde at 4°C overnight, then dehydrated
using a series of ethanol washes, cleared in xylene, and
embedded in paraffin. Ovarian sections of 4 μm thick-
ness were prepared for hematoxylin and eosin (HE)
staining.
HE staining and follicle classification
The sections were deparaffinized in xylene, hydrated using
a series of ethanol washes, and stained with HE using
standard protocols. Sections were mounted using Canada
balsam and observed under a light microscope. Every sec-
tion from each ovary was used for follicle counting, and
then correcting for double counting. Follicles were classi-
fied according to a previous study [26] as follows: primor-
dial follicle (an oocyte surrounded by one layer of flattened
granulosa cells), primary follicle (an oocyte surrounded by
one layer of cuboidal granulosa cells), secondary follicle
(two or three layers of cuboidal granulosa cells with no an-
tral space), and antral follicle (more than four layers of
granulosa cells with one or more independent antral spaces
or with a cumulus granulosa cell layer). In some cases, an-
tral follicles showed no antral space in cross section analysis
but were considered antral if they contained ≥5 granulosa
cell layers. Follicles were classified as either healthy (intact
basal-lamina, oocyte with no more than three cytoplasmic
vacuoles, intact germinal vesicle and nucleolus) or atretic
(apoptotic). Antral follicles were considered atretic if they
contained at least 20 apoptotic granulosa cells (defined by
the appearance of apoptotic bodies in the granulosa cell
layer), disorganized granulosa cells, a degenerating oocyte,
or a fragmentation of the oocyte nucleus [27].
Western blot analysis
Ovarian tissue samples were homogenized in PBS with a
Teflon-glass homogenizer (Thomas Scientific, Swedesboro,
NJ, USA) on ice and sonicated. Protein concentrations
were determined by BCA protein assay (TIANGEN BIO-
TECH, Beijing, China). The protein samples were sepa-
rated by SDS-PAGE and transferred onto nitrocellulose
membranes (BioTrace™ NT, Port Washington, NY, USA).
The membranes were blocked in 5% nonfat dry milk in
tris-buffered-saline with tween 20 (TBST) for 1 h andincubated with a primary antibody against SIRT1, SIRT6,
and FOXO3a (1:200 dilution, Santa Cruz Biotechnology,
CA, USA), NRF1 (1:400 dilution, Santa Cruz Biotechnol-
ogy, CA, USA), p53 (1:600 dilution, Santa Cruz Biotech-
nology, CA, USA) or β-action (1:1,000 dilution, Santa Cruz
Biotechnology, CA, USA) over-night at 4°C, followed by
the incubation with a secondary (horseradish peroxidase-
conjugated) anti-rabbit or anti-mouse antibody (1:5,000 di-
luted) at room temperature for 1 h. Bands were visualized
with a chemiluminescence reagent (Thermo Fisher Scien-
tific, Waltham, MA, USA). Band intensities were analyzed
using the Quantity One software (Bio-Rad Laboratories
Pty. Ltd., Hercules, CA, USA). β-actin was used as a load-
ing control.
Statistical analysis
All results are expressed as the means ± SEM (n = 7 in
every group) and analyzed by the SPSS 17.0 software. A
one-way ANOVA was used to compare the data among
groups. A P value less than 0.05 was considered as stat-
istical significance (P < 0.05).
Results
All mice were alive at the end of the 26-week treatment,
and no superficial abnormalities or tumors were found
in the abdomen and other parts of the body.
Energy intake, body weight, and visceral fat
The pattern of energy intake of the SRT1720 group was
as similar as that of the NC group before SRT1720 treat-
ment. After SRT1720 treatment, the energy intake of the
SRT1720 group gradually decreased compared to the
NC group. At the end of treatment, the energy intake of
the SRT1720 group (10.80 ± 0.18 kcal/day) was compar-
able to that of the CR group (9.5 kcal/day, P > 0.05) but
lower than that of the NC group (13.58 ± 0.25 kcal/day,
P < 0.05) (Figure 1).
The body weight among groups was comparable to each
































Figure 3 Comparison of ovarian weight among groups. Values
were represented as means ± SEM. *P < 0.05 vs the control group.
CR, calorie restriction; NC, normal control.




NC (n = 7) % CR (n = 7) % SRT1720 (n = 7) %
4 months
Regular cycling 7 5 (71.43%) 7
Irregular cycling 0 2 (28.57%) 0
5 months
Regular cycling 7 4 (57.14%) 7
Irregular cycling 0 3 (42.86%) 0
6 months
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from the beginning to the end of the treatment (21.45 ± 0.11
vs 23.34 ± 0.22 g, P < 0.05; 21.39 ± 0.20 vs 22.53 ± 0.23 g, P <
0.05). The body weight in the CR group was similar from
the beginning to the end (21.54 ± 0.36 vs 22.11 ± 0.19 g, P >
0.05). The pattern of body weight of the SRT1720 group
was as similar as that of the NC group before SRT1720
treatment. After SRT1720 treatment, body weight of the
SRT1720 group decreased compared to the NC group. At
the end of the experiment, the body weight of the SRT1720
mice was similar to that of the CR mice (22.53 ± 0.23 vs
22.11 ± 0.19 g, P > 0.05). But the body weight of the
SRT1720 mice or the CR mice was lower than that of the
NC mice (22.53 ± 0.23 vs 23.34 ± 0.22 g, P < 0.05; 22.11 ±
0.19 vs 23.34 ± 0.22 g, P < 0.05) (Figure 2).
The visceral fat weight in the SRT1720 group was similar
to that in the CR group (0.36 ± 0.01 vs 0.29 ± 0.01 g, P >
0.05). But the visceral fat weight in the SRT1720 group or
the CR group decreased compared to that of the NC group
(0.36 ± 0.01 vs 0.53 ± 0.03 g, P < 0.05; 0.29 ± 0.01 vs 0.53 ±
0.03 g, P < 0.05).
Ovarian weight
The ovarian weight in the SRT1720 group was similar to
that in the CR group (3.69 ± 0.10 vs 3.59 ± 0.09 mg, P >
0.05). But the ovarian weight in the SRT1720 group or the
CR group was lower than that of the NC group (3.69 ±
0.10 vs 4.19 ± 0.11 mg, P < 0.05; 3.59 ± 0.09 vs 4.19 ±
0.11 mg, P < 0.05) (Figure 3).
Estrous cycle
We examined the estrous cycles of all mice before the
treatment and found that all of them represented regu-
larly estrous cycles (4 to 5 days). During the experiment,
mice in the CR group gradually lost their regular estrous
cycles. At the end of the experiment, six (85.71%) mice
in the CR group showed irregular estrous cycle, and all
of them displayed estrous cycles >5 days in intermittent.



















Figure 2 Changes in the body weight of mice (the mice in the
SRT1720 group were given the standard chow containing
SRT1720 (50 mg/kg B.W.) every other day for the last 8 weeks).
CR, calorie restriction; NC, normal control.during the first 5 months of treatment, but 1 (14.29%)
mouse showed irregular estrous cycle at the sixth month
of treatment. Before SRT1720 treatment, all (100%) mice
in the SRT1720 group also displayed regular estrous cy-
cles. During SRT1720 treatment, 5 (71.43%) mice in the
SRT1720 group showed irregular estrous cycle (Table 1).Regular cycling 7 3 (42.86%) 7
Irregular cycling 0 4 (57.14%) 0
7 months
Regular cycling 7 3 (42.86%) 7
Irregular cycling 0 4 (57.14%) 0
8 months
Regular cycling 7 2 (28.57%) 2 (28.57%)
Irregular cycling 0 5 (71.43%) 5 (71.43%)
9 months
Regular cycling 6 (85.71%) 1 (14.29%) 2 (28.57%)
Irregular cycling 1 (14.29%) 6 (85.71%) 5 (71.43%)
Note: The SRT1720 treatment started at the beginning of eighth month of age


















































Figure 5 Comparison of the total number of follicles, survival
follicles, and atretic follicles among groups. *P < 0.05 vs the NC
group. **P < 0.05 vs the CR group. CR, calorie restriction; NC,
normal control.
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Comparison of the total number of follicles, surviving
follicles, and atretic follicles among groups
HE staining results showed that adult mouse ovaries were
mainly composed of surviving follicles (primordial, pri-
mary, secondary, and antral follicles), corpora lutea, and
atretic follicles (Figure 4). The total number of follicles was
defined as the sum of the number of all stages of follicles
in one ovary. The total number of follicles in the SRT1720
group was comparable to that in the NC group (802 ± 21
vs 794 ± 19, P > 0.05), either of them was less than that in
the CR group (802 ± 21 or 794 ± 19 vs 891 ± 29, P < 0.05).
The number of surviving follicles in the ovaries of the
SRT1720 group was less than that of the CR group (707 ±
22 vs 802 ± 27, P < 0.05) but more than that of the NC
group (707 ± 22 vs 658 ± 18, P < 0.05). The number of
atretic follicles in ovaries of the SRT1720 group was similar
to that of the CR group (59 ± 10 vs 54 ± 7, P > 0.05) but less
than that of the NC group (59 ± 10 vs 73 ± 10, P < 0.05)
(Figure 5).
Comparison of the number of follicles at different stages
among groups
The number of primordial follicles in the ovaries of the
SRT1720 group was less than that of the CR group (321 ±
19 vs 418 ± 26, P < 0.05) but more than that of the NC
group (321 ± 19 vs 258 ± 20, P < 0.05). The number of pri-
mary follicles in the ovaries of the SRT1720 group was
similar to that of the CR group (230 ± 19 vs 241 ± 15, P >Figure 4 A representative section of mouse ovary stained
by HE.0.05) but more than that of the NC group (230 ± 19 vs
210 ± 16, P < 0.05). The number of secondary follicles in
the ovaries of the SRT1720 group was similar to that of
the CR group (94 ± 14 vs 85 ± 12, P > 0.05) but less than
that of the NC group (94 ± 14 vs 114 ± 10, P < 0.05). The
number of antral follicles in the SRT1720 group was simi-
lar to that of the CR group (62 ± 7 vs 58 ± 9, P > 0.05) but
less than that of the NC group (62 ± 7 vs 77 ± 9, P < 0.05).
The number of corpora lutea in the ovaries of the
SRT1720 group was similar to that of the CR group (36 ±
6 vs 34 ± 3, P > 0.05) but less than that of the NC group
(36 ± 6 vs 62 ± 10, P < 0.05) (Figure 6).SIRT1 signaling was enhanced in the ovaries of the
SRT1720 group and the CR group
Our Western blot results showed that the protein expres-
sion of SIRT1, SIRT6, NRF1, and FOXO3a in the CR
group and the SRT1720 group increased compared to the
NC group. However, p53 decreased in the CR group and
the SRT1720 group compared to the NC group (P < 0.05).
The expression levels of SIRT1, SIRT6, NRF1, FOXO3a,
and p53 proteins in the SRT1720 group were similar to
those in the CR group (P > 0.05) (Figure 7).Discussion
Menopause is defined as the permanent cessation of
menses and irreversible termination of fertility, because
of the gradual depletion of oocytes. It leads to conse-
quences that include osteoporosis, obesity, sexual dys-
function, depression, anxiety, and a higher incidence of
Alzheimer’s disease and cardiovascular disease [28,29].
Increased life expectancy leads to increased age-
associated health issues in both sexes. Women, who gen-
erally live longer than men, will spend nearly a third of






























































Figure 6 The distribution of follicles at different stages in the
control group, CR group, and SRT1720 group. *P < 0.05 vs the
NC group. **P < 0.05 vs the CR group. CR, calorie restriction; NC,
normal control.
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currently been an area of great interest.
In this study, we found that the body weight and visceral
fat in adult female mice 8 weeks after SRT1720 treatment
were similar to those in the CR group but lower than those
in the NC group. Moreover, SRT1720 treatment could de-
crease mouse intake. As CR treatment, SRT1720 could de-
crease mouse intake and body weight. It has been
established that the female reproductive aging is associated
with a reduced ovarian follicle reserve and gradual declines
in regular estrous cyclicity at middle age [30,31]. Hence,
we examined the status of estrous cycle among the groups.
We found that all the mice displayed regular estrous cycle
at the beginning of the experiment. During the experiment,
the estrous cycle of mice in the CR group gradually be-
came irregular. At the end, 14.29% NC mice represented
irregularly. The incidence of irregular estrous cycle was
85.71% in the CR group and 71.43% in the SRT1720 group.
The most abnormal CR mice and SRT1720 mice displayed
estrous cycles >5 days. We supposed that irregular estrous
cycle of the CR mice and the SRT1720 mice resulted from
insufficient estrogen secreted by fewer mature follicles.
This is in agreement with the following follicle count re-
sults. Follicle count results showed that the number of sur-
viving follicles in ovaries of the SRT1720 group was less
than that of the CR group but more than that in the NC
group, and the number of atretic follicles was fewer than
that of the NC group. This indicated that both CR and
SRT1720 treatment could inhibit follicle development and
follicle loss and promote follicle reserve. The number of
primordial follicles in the SRT1720 group was more than
that of the NC group though it was less than that of the
CR group. However, the numbers of primary follicles,secondary follicles, antral follicles, and corpora lutea in the
SRT1720 group were similar to those in the CR group.
These suggest that both SRT1720 and CR may inhibit the
activation of primordial follicles, follicle development, fol-
licle maturation, and ovulation. Because of fewer larger fol-
licles and corpora lutea, the volume and weight of the
ovaries in the SRT1720 group or the CR group were
smaller than those in the NC group.
To explore whether SIRT1 signaling was involved in
the ovarian follicle development, we examined the ex-
pression of SIRT1 and related factors by Western blot.
Kim et al. [19] recently reported that SIRT1 is involved
in maintaining SIRT6 expression and is required for
SIRT6 induction during fasting. The authors further
found that there are NRF-1 binding sites in the SIRT6
promoter, and its expression was regulated by CR. In
addition, their study showed that FOXO3a was also in-
volved in the regulation of SIRT6 expression, and the
downregulation of FOXO3a prevented SIRT6 from
responding to the induction of CR and SIRT1, suggest-
ing that SIRT1, FOXO3a, and NRF-1 may form a com-
plex on the SIRT6 promoter, which could be enhanced
by glucose deprivation. Therefore, we examined the ef-
fect of CR and SRT1720 on SIRT1, FOXO3a, NRF1, and
SIRT6 protein expression. Our results showed that both
CR and SRT1720 could upregulate SIRT1, FOXO3a,
NRF1, and SIRT6 protein expression in the ovary.
p53 is a tumor suppressor gene that is a positive regu-
lator of apoptosis in its native form (wild-type). DNA
damage causes a rapid increase in the total concentra-
tion of p53 protein by increased gene transcription and
the stabilization of normally rapidly degraded p53 pro-
tein which leads to the suppression of cell growth and
p53-mediated cell-cycle arrest [32]. The expression of
p53 protein in the apoptotic granulosa cells of atretic folli-
cles suggests its possible role in atresia [20]. Moreover, p53
is regulated by SIRT1-mediated deacetylation. SIRT1 pro-
tein regulates p53 acetylation and p53-dependent apoptosis
[33]. In addition, Ghafari et al. showed that p53 gene is in-
volved in the regulation and selection of oocytes at check-
points, such that oocytes that would otherwise be lost may
persist when p53 is absent or reduced [34]. These data in-
dicate that p53 is associated with follicle atresia. Therefore,
we also examined the effect of CR and SRT1720 on p53
protein expression in the ovary. The results showed that
both CR and SRT1720 could inhibit p53 protein expression
in the ovaries, which is probably due to the activation of
SIRT1.
Conclusions
Taken together, our present study indicates that CR inhibits
the activation of primordial follicles and development of
follicles at different stages, thus preserving the reserve of
follicle pool and prolonging the ovarian lifespan (at least
Figure 7 The protein levels of SIRT1, SIRT6, FOXO3a, NRF-1, and p53 in mouse ovaries. (A) Western blot results. (B) Plot of protein
expression. β-Actin was used as internal control. Data are expressed as means ± SEM. *P < 0.05 vs the NC group. CR, calorie restriction; FOXO3a,
forkhead box group O; NC, normal control; NRF1, nuclear respiratory factor 1; SIRT1, silent information regulator 2 related enzyme 1.
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SIRT1 specific activator (SRT1720) to imitate CR signal.
However, pharmacological application of SRT1720 will be
further investigated in the future study.
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